{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:42:13Z","timestamp":1793317333245,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.yrtph.2022.105315","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:32:17Z","timestamp":1670329937000},"page":"105315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impact of chemical structure on the in vitro hydrolysis of fatty esters of 2-ethylhexanoic acid or 2-ethylhexanol and extrapolation to the in vivo situation"],"prefix":"10.1016","volume":"137","author":[{"given":"Cindy","family":"Obringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corie A.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yrtph.2022.105315_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/dmd.121.000774","article-title":"Comparison of tissue abundance of non-cytochrome P450 drug-metabolizing enzymes by quantitative proteomics between humans and laboratory animal species","volume":"50","author":"Basit","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105315_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1523-1747.2001.01247.x","article-title":"A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical dissector method and the confocal laser scanning microscope","volume":"116","author":"Bauer","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.yrtph.2022.105315_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/1523-1747.ep12541516","article-title":"Counting and sizing of epidermal cells in normal human skin","volume":"70","author":"Bergstresser","year":"1978","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105315_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.comtox.2018.08.005","article-title":"Dosimetry considerations for in vivo and in vitro test data and a novel surrogate iTTC approach for read-across based on metabolites","volume":"10","author":"Blackburn","year":"2019","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105315_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104656","article-title":"An interim internal Threshold of Toxicologic Concern (iTTC) for chemicals in consumer products, with support from an automated assessment of ToxCast\u2122 dose response data","volume":"114","author":"Blackburn","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105315_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol. Ind. Health"},{"issue":"25","key":"10.1016\/j.yrtph.2022.105315_bib7","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1021\/jm990145k","article-title":"Quantitative Structure\u2212Metabolism relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters","volume":"42","author":"Buchwald","year":"1999","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105315_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1018981515480","article-title":"A new method for estimating dermal absorption from chemical exposure. 1. General approach","volume":"10","author":"Cleek","year":"1993","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105315_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/dmd.120.000168","article-title":"Label-Free quantitative proteomics and substrate-based mass spectrometry imaging of xenobiotic metabolizing enzymes in ex vivo human skin and a human living skin equivalent model","volume":"49","author":"Couto","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.yrtph.2022.105315_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105315_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijpharm.2006.03.007","article-title":"High throughput microsomal stability assay for insoluble compounds","volume":"317","author":"Di","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.yrtph.2022.105315_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2005.03.022","article-title":"Development and application of high throughput plasma stability assay for drug discovery","volume":"297","author":"Di","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2022.105315_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejmech.2012.06.043","article-title":"Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design","volume":"57","author":"Di","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105315_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jat.3914","article-title":"Use of human liver and EpiSkin\u2122 S9 subcellular fractions as a screening assay to compare the in vitro hepatic and dermal metabolism of 47 cosmetics-relevant chemicals","volume":"40","author":"Eilstein","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105315_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yrtph.2019.01.016","article-title":"Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: discussions from the Cosmetics Europe iTTC Working Group workshop","volume":"103","author":"Ellison","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105315_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104990","article-title":"Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids","volume":"69","author":"Ellison","year":"2020","journal-title":"Toxicol. Vitro"},{"issue":"3 Suppl. l","key":"10.1016\/j.yrtph.2022.105315_bib17","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1177\/1091581815617794","article-title":"Safety assessment of alkyl ethylhexanoates as used in cosmetics","volume":"34","author":"Fiume","year":"2015","journal-title":"Int. J. Toxicol."},{"issue":"2 Suppl. l","key":"10.1016\/j.yrtph.2022.105315_bib18","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/1091581815594027","article-title":"Safety assessment of alkyl esters as used in cosmetics","volume":"34","author":"Fiume","year":"2015","journal-title":"Int. J. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105315_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jat.3905","article-title":"Comparison of the metabolism of 10 cosmetics-relevant chemicals in EpiSkin\u2122 S9 subcellular fractions and in vitro human skin explants","volume":"40","author":"G\u00e9ni\u00e8s","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105315_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tiv.2018.08.004","article-title":"Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance","volume":"53","author":"Gouliarmou","year":"2018","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105315_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2021.100177","article-title":"Cosmetics Europe evaluation of 6 in silico skin penetration models","volume":"19","author":"Gr\u00e9goire","year":"2021","journal-title":"Comput. Toxicol."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105315_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/pharmaceutics13060807","article-title":"Assessment of vehicle volatility and deposition layer thickness in skin penetration models","volume":"13","author":"Hamadeh","year":"2021","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.yrtph.2022.105315_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/138920008786485164","article-title":"Methods for predicting in vivo pharmacokinetics using data from in vitro assays","volume":"9","author":"Houston","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.yrtph.2022.105315_bib26","series-title":"Saturated Aliphatic Acyclic Linear Primary Alcohols, Aldehydes, and Acid. 49th Meeting of the Joint FAO\/WHO Expert Committee on Food Additives","year":"1998"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105315_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0278-6915(97)00168-3","article-title":"2-Ethylhexanoic acid: subchronic oral toxicity studies in the rat and mouse","volume":"36","author":"Juberg","year":"1998","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105315_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.yrtph.2017.12.026","article-title":"Structure activity relationship (SAR) toxicological assessments: the role of expert judgment","volume":"92","author":"Lester","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105315_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.105051","article-title":"Metabolism and plasma protein binding of 16 straight- and branched-chain parabens in in vitro liver and skin models","volume":"72","author":"Lester","year":"2021","journal-title":"Toxicol. Vitro"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105315_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/molecules13020204","article-title":"Trimethyl lock: a stable chromogenic substrate for esterases","volume":"13","author":"Levine","year":"2008","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.yrtph.2022.105315_bib31","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1124\/dmd.106.010793","article-title":"Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes","volume":"34","author":"Lu","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105315_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.taap.2015.05.016","article-title":"Extrapolation of systemic bioavailability assessing skin absorption and epidermal and hepatic metabolism of aromatic amine hair dyes in vitro","volume":"287","author":"Manwaring","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105315_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yrtph.2013.03.005","article-title":"Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment","volume":"66","author":"Meek","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"11","key":"10.1016\/j.yrtph.2022.105315_bib34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2022.105315_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104918","article-title":"Effect of chain length and branching on the in vitro metabolism of a series of parabens in human liver S9, human skin S9, and human plasma","volume":"122","author":"Obringer","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105315_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03602530701690366","article-title":"Drug-metabolizing enzymes in the skin of man, rat, and pig","volume":"39","author":"Oesch","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.yrtph.2022.105315_bib37","series-title":"Encyclopedia of Food and Health","first-page":"623","article-title":"Fatty acids: fatty acids","author":"Petrovic","year":"2016"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105315_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1872312810666160223121836","article-title":"Efficiency in drug discovery: liver S9 fraction assay as a screen for metabolic stability","volume":"10","author":"Richardson","year":"2016","journal-title":"Drug Metabol. Lett."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105315_bib39","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jps.20322","article-title":"Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases","volume":"94","author":"Rodgers","year":"2005","journal-title":"J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105315_bib40","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J. Pharmaceut. Sci."},{"issue":"7","key":"10.1016\/j.yrtph.2022.105315_bib41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jat.3427","article-title":"Comparison of protocols measuring diffusion and partition coefficients in the stratum corneum","volume":"37","author":"Rothe","year":"2017","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105315_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01059626","article-title":"Clearance concepts in pharmacokinetics","volume":"1","author":"Rowland","year":"1973","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105315_bib43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.yrtph.2015.05.016","article-title":"A strategy for structuring and reporting a read-across prediction of toxicity","volume":"72","author":"Schultz","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105315_bib44","series-title":"Encyclopedia of Drug Metabolism and Interactions","article-title":"Methods for determination of enzyme kinetics and metabolic rates","author":"Subramanian","year":"2012"},{"key":"10.1016\/j.yrtph.2022.105315_bib50","doi-asserted-by":"crossref","unstructured":"Terasaka S, Hayashi A, Nukada Y, Yamane M. Investigating the uncertainty of prediction accuracy for the application of physiologically based pharmacokinetic models to animal-free risk assessment of cosmetic ingredients. Regul Toxicol Pharmacol. 2022 Nov;135:105262. doi: 10.1016\/j.yrtph.2022.105262. Epub 2022 Sep 11. PMID: 36103952.","DOI":"10.1016\/j.yrtph.2022.105262"},{"issue":"7","key":"10.1016\/j.yrtph.2022.105315_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041721","article-title":"Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling","volume":"7","author":"van Eijl","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105315_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/dmd.119.089235","article-title":"Comparative proteomics analysis of human liver microsomes and S9 fractions","volume":"48","author":"Wang","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105315_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"Commentary: a physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105315_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yrtph.2009.09.006","article-title":"A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments","volume":"56","author":"Wu","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:36:17Z","timestamp":1759494977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230022002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":47,"alternative-id":["S0273230022002021"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105315","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of chemical structure on the in vitro hydrolysis of fatty esters of 2-ethylhexanoic acid or 2-ethylhexanol and extrapolation to the in vivo situation","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105315"}}